213 related articles for article (PubMed ID: 30081731)
1. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
[TBL] [Abstract][Full Text] [Related]
3. Respiratory Complications in Patients with Hyper IgM Syndrome.
Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
5. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
[TBL] [Abstract][Full Text] [Related]
6. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
[TBL] [Abstract][Full Text] [Related]
7. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
[TBL] [Abstract][Full Text] [Related]
8. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
Meng X; Yang B; Suen WC
Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
[TBL] [Abstract][Full Text] [Related]
9. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
[TBL] [Abstract][Full Text] [Related]
10. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity.
Fazel A; Kashef S; Aleyasin S; Harsini S; Karamizadeh Z; Zoghi S; Flores SK; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2017; 45(1):82-86. PubMed ID: 27789066
[TBL] [Abstract][Full Text] [Related]
11. The polymorphism p.G219R of CD40L does not cause immunological alterations in vivo: conclusions from a X-linked hyper IgM syndrome kindred.
Martinez-Martinez L; Gonzalez-Santesteban C; Badell I; de la Calle-Martin O
Mol Immunol; 2012 Oct; 52(3-4):237-41. PubMed ID: 22750225
[TBL] [Abstract][Full Text] [Related]
12. Autosomal recessive hyper IgM syndrome associated with activation-induced cytidine deaminase gene in three Turkish siblings presented with tuberculosis lymphadenitis - Case report.
Patiroglu T; Akar HH; van der Burg M; Unal E
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):267-74. PubMed ID: 26551569
[TBL] [Abstract][Full Text] [Related]
13. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome.
Mahdaviani SA; Hirbod-Mobarakeh A; Wang N; Aghamohammadi A; Hammarström L; Masjedi MR; Pan-Hammarström Q; Rezaei N
Expert Rev Clin Immunol; 2012 Aug; 8(6):539-46. PubMed ID: 22992148
[TBL] [Abstract][Full Text] [Related]
14. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
[TBL] [Abstract][Full Text] [Related]
15. Hyper IgM Syndrome: a Report from the USIDNET Registry.
Leven EA; Maffucci P; Ochs HD; Scholl PR; Buckley RH; Fuleihan RL; Geha RS; Cunningham CK; Bonilla FA; Conley ME; Ferdman RM; Hernandez-Trujillo V; Puck JM; Sullivan K; Secord EA; Ramesh M; Cunningham-Rundles C
J Clin Immunol; 2016 Jul; 36(5):490-501. PubMed ID: 27189378
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic analysis of Hungarian patients with the hyper-immunoglobulin M syndrome.
Erdos M; Lakos G; Dérfalvi B; Notarangelo LD; Durandy A; Maródi L
Mol Immunol; 2008 Jan; 45(1):278-82. PubMed ID: 17553565
[TBL] [Abstract][Full Text] [Related]
17. [Hyper-IgM syndrome in members of two unrelated Chilean families: molecular and mutation analysis].
Luttges PD; Retamal DF; Spencer MY; Carrión FA; Valenzuela VM; Navarro SV; De Cornejo ML
Rev Med Chil; 2004 Oct; 132(10):1179-88. PubMed ID: 15631205
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity in hyper-IgM syndrome.
Jesus AA; Duarte AJ; Oliveira JB
J Clin Immunol; 2008 May; 28 Suppl 1():S62-6. PubMed ID: 18246414
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
20. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
Ouadani H; Ben-Mustapha I; Ben-Ali M; Larguèche B; Jovanic T; Garcia S; Arcangioli B; Elloumi-Zghal H; Fathallah D; Hachicha M; Masmoudi H; Rougeon F; Barbouche MR
Mol Immunol; 2016 Nov; 79():77-82. PubMed ID: 27716525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
